Colfax Corporation (CFX) |
| 39.06 -1.53 (-3.77%) 04-05 00:00 |
| Open: | 40.6 |
| High: | 40.67 |
| Low: | 38.88 |
| Volume: | 2,953,345 |
| Market Cap: | 2,122(M) |
| PE Ratio: | 28.55 |
| Exchange: | New York Stock Exchange |
| Industry: | Industrial - Machinery |
| Sector: | Industrials |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 40.67 |
| Resistance 1: | 39.99 |
| Pivot price: | 39.06 |
| Support 1: | 38.88 |
| Support 2: | 32.35 |
| 52w High: | 94.02802 |
| 52w Low: | 38.88 |
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
| EPS | 0.710 |
| Book Value | 29.630 |
| PEG Ratio | 0.89 |
| Gross Profit | 8.334 |
| Profit Margin (%) | 2.92 |
| Operating Margin (%) | 8.78 |
| Return on Assets (ttm) | 2.7 |
| Return on Equity (ttm) | 3.2 |
Mon, 28 Mar 2022
Colfax Announces Board of Directors for Post-Spinoff ESAB - GlobeNewswire
Tue, 22 Feb 2022
Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results - Yahoo Finance
Tue, 31 Aug 2021
DJO® Introduces New EMPOWR Dual Mobility™ Hip System at AAOS - Business Wire
Mon, 26 Apr 2021
DJO® Acquires MedShape, Inc. - Business Wire
Tue, 30 Mar 2021
DJO Invests in Next-Generation Augmented Reality Technology Primed for ASC Market Growth - Business Wire
Thu, 16 May 2019
KPS to Buy Howden from Colfax - Private Equity Professional
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |